Cardiac Disease, Diabetes, Rheumatic Diseases
Conditions
Brief summary
The modifications of the medicinal treatments secondary to the hospitalizations have multiple reasons: reassessment of the previous treatment (conciliation), new therapeutic necessities, potential risk of iatrogeny or of drug interaction, restrictions of the therapeutic booklet, classification in reserve or hospital prescription ... These modifications are potentially generating extra costs for the Health Insurance and are monitored under the terms of the Contract of Good Use. The aims of this analysis are to define the medical-pharmaceutical rationale of the treatment changes imposed by hospitalization in a university-hospital center, their influence on the security of the medical treatment of patients and their financial implications for healthcare organizations
Interventions
OTHERcollection of prescription data
collection of prescription data before and after a hospitalization
Sponsors
Assistance Publique Hopitaux De Marseille
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patient social insured * Patient belonging to the general social security scheme * Patient followed in cardiology, rheumatology, geriatrics or diabetology departments no
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| entry orders before hospitalization | 15 months |
| exit orders after hospitalization | 15 months |
Countries
France
Outcome results
None listed